| Cytomegalovirus and inflammatory bowel diseases (IBD) with a special focus on the link with ulcerative colitis (UC) A Jentzer, P Veyrard, X Roblin, P Saint-Sardos, N Rochereau, S Paul, ... Microorganisms 8 (7), 1078, 2020 | 35 | 2020 |
| IgG4 Valency Modulates the Pathogenicity of Anti–Neurofascin-155 IgG4 in Autoimmune Nodopathy A Jentzer, A Attal, C Roué, J Raymond, C Lleixà, I Illa, L Querol, G Taieb, ... Neurology: Neuroimmunology & Neuroinflammation 9 (5), e200014, 2022 | 15 | 2022 |
| Evaluation of infliximab and anti-infliximab LISA-TRACKER immunoassays for the therapeutic drug monitoring of SB2 infliximab biosimilar A Jentzer, AE Berger, R Labetoulle, A Haccourt, X Roblin, S Paul Therapeutic Drug Monitoring 40 (6), 749-753, 2018 | 11 | 2018 |
| Neuromyelitis optica spectrum disorder following COVID-19 infection with increase in pre-existing anti-aquaporin-4 antibodies A Jentzer, C Carra-Dallière, C Lozano, S Riviere, O Darmon, X Ayrignac, ... Journal of Neurology 269 (6), 2850-2853, 2022 | 6 | 2022 |
| Nouveaux marqueurs diagnostiques et pronostiques des maladies chroniques inflammatoires intestinales A Jentzer, AE Depincé-Berger, C Genin, X Roblin, S Paul Revue Francophone des Laboratoires 2016 (484), 49-56, 2016 | 3 | 2016 |
| Comparative evaluation of four commercially available immunoassays for therapeutic drug monitoring of infliximab and adalimumab F Rissel, Y Cazaubon, S Saffar, R Altwegg, M Artasone, C Lozano, ... International Journal of Molecular Sciences 24 (12), 10379, 2023 | 2 | 2023 |
| Effect of monovalency on anti-contactin-1 IgG4 G Taieb, A Jentzer, E Vegezzi, C Lleixà, I Illa, L Querol, JJ Devaux Frontiers in Immunology 14, 1021513, 2023 | 2 | 2023 |
| Immune‐mediated diseases involving central and peripheral nervous systems A Leboyan, F Esselin, AL Bascou, C Duflos, I Ion, M Charif, G Castelnovo, ... European Journal of Neurology 30 (2), 490-500, 2023 | 2 | 2023 |
| Cytomegalovirus and infl ammatory bowel diseases, with a special focus on its role in ulcerative colitis A Jentzer, N Williet, X Roblin, N Rochereau, S Paul, B Pozzetto, S Pillet Virologie 21 (6), 287-302, 2017 | 1 | 2017 |
| Post-polio syndrome is not a dysimmune condition. I Laffont, C Duflos, C Hirtz, K Bakhti, A Gelis, C Palayer, V Macioce, ... European Journal of Physical and Rehabilitation Medicine, 2024 | | 2024 |
| Les nodopathies auto-immunes: focus sur les auto-anticorps pathogènes et conduite à tenir en laboratoire A Jentzer, G Taieb, T Vincent, J Devaux Revue Francophone des Laboratoires 2023 (553), 55-63, 2023 | | 2023 |
| MYOSITIS SPECIFIC AND NOVEL MYOSITIS ASSOCIATED AUTOANTIBODIES IN DERMATOMYOSITIS SUBPHENOTYPES OF A FRENCH COHORT T Vincent, K Martinez, A Jentzer, M Best, D Bessis, MA Aure, A Seaman, ... CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 41 (2), 463-463, 2023 | | 2023 |
| CLINICAL PERFORMANCE OF MYOSITIS SPECIFIC AND NOVEL MYOSITIS ASSOCIATED AUTOANTIBODIES IN A COHORT OF DERMATOMYOSITIS PATIENTS FROM FRANCE A Seaman, T Vincent, C Bentow, V Adani, MA Aure, A Jentzer, D Bessis, ... CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 41 (2), 462-463, 2023 | | 2023 |
| Effect of monovalency on anti-contactin-1 IgG4 L Querol, G Taieb, A Jentzer, E Vegezzi, C Lleixà, I Illa, J Devaux Frontiers in Immunology 14, 2023 | | 2023 |
| Impact of Dextran-Sodium-Sulfate-Induced Enteritis on Murine Cytomegalovirus Reactivation A Jentzer, S Fauteux-Daniel, P Verhoeven, A Cantais, MY Novoa, ... Viruses 14 (12), 2595, 2022 | | 2022 |
| Diagnostic and therapeutic management of mast cells activation syndromes E Clark, A Schiffmann, A Jentzer, P Demolya, P Guilpaina, D Caimmi REVUE FRANCAISE D ALLERGOLOGIE 62 (5), 492-496, 2022 | | 2022 |
| Prise en charge diagnostique et thérapeutique des syndromes d’activation mastocytaire E Clark, A Schiffmann, A Jentzer, P Demoly, P Guilpain, D Caimmi Revue Française d'Allergologie 62 (5), 492-496, 2022 | | 2022 |
| Impact of Dextran-Sodium-Sulfate-Induced Enteritis on Murine Cytomegalovirus Reactivation. Viruses 2022, 14, 2595 A Jentzer, S Fauteux-Daniel, P Verhoeven, A Cantais, MY Novoa, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| Impact de la colite à cytomégalovirus sur les poussées de rectocolite hémorragique: approches expérimentales et études cliniques A Jentzer Université de Lyon, 2021 | | 2021 |
| Valency dictates anti-Nfasc155 IgG4 pathogenicity A Attal, A Jentzer, M Poncelet, G Taieb, L Querol, J Devaux JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 26 (3), 310-311, 2021 | | 2021 |
